The goal of the project is to study the risk of coccidioidomycosis (valley fever) in patients receiving anti-TNF and other biologic agents for inflammatory arthritis in Tucson, Arizona.
Retrospective chart review of all patients with an inflammatory arthritis seen at the University Rheumatology clinic since January 2000.
Study Type
OBSERVATIONAL
Enrollment
598
University of Arizona - Arizona Arthritis Center
Tucson, Arizona, United States
Determine the incidence rate and calculate the risk of coccidioidomycosis in patients receiving various anti-TNF agents or other biologics, and patients not receiving these agents for their inflammatory arthritis
Time frame: one year
To calculate the incidence density of coccidioidomycosis cases in patients receiving each drug.
Time frame: One year
To compare number of disseminated cases of coccidioidomycosis in each group
Time frame: One year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.